TY - JOUR
T1 - Variants That Affect Function of Calcium Channel TRPV6 Are Associated With Early-Onset Chronic Pancreatitis
AU - Masamune, Atsushi
AU - Kotani, Hiroshi
AU - Sörgel, Franziska Lena
AU - Chen, Jian Min
AU - Hamada, Shin
AU - Sakaguchi, Reiko
AU - Masson, Emmanuelle
AU - Nakano, Eriko
AU - Kakuta, Yoichi
AU - Niihori, Tetsuya
AU - Funayama, Ryo
AU - Shirota, Matsuyuki
AU - Hirano, Tatsuya
AU - Kawamoto, Tetsuya
AU - Hosokoshi, Atsuki
AU - Kume, Kiyoshi
AU - Unger, Lara
AU - Ewers, Maren
AU - Laumen, Helmut
AU - Bugert, Peter
AU - Mori, Masayuki X.
AU - Tsvilovskyy, Volodymyr
AU - Weißgerber, Petra
AU - Kriebs, Ulrich
AU - Fecher-Trost, Claudia
AU - Freichel, Marc
AU - Diakopoulos, Kalliope N.
AU - Berninger, Alexandra
AU - Lesina, Marina
AU - Ishii, Kentaro
AU - Itoi, Takao
AU - Ikeura, Tsukasa
AU - Okazaki, Kazuichi
AU - Kaune, Tom
AU - Rosendahl, Jonas
AU - Nagasaki, Masao
AU - Uezono, Yasuhito
AU - Algül, Hana
AU - Nakayama, Keiko
AU - Matsubara, Yoichi
AU - Aoki, Yoko
AU - Férec, Claude
AU - Mori, Yasuo
AU - Witt, Heiko
AU - Shimosegawa, Tooru
N1 - Funding Information:
Funding This work was supported in part by Grant-in-Aid from the Japan Society for the Promotion of Science ( 16K15421 , 17K15916 , 19K17450 ); Pancreas Research Foundation of Japan; the HIROMI Medical Research Foundation; the Mother and Child Health Foundation; the Smoking Research Foundation , the Ministry of Health , Labour, and Welfare of Japan; Conseil Régional de Bretagne; the Association des Pancréatites Chroniques Héréditaires; the Association de Transfusion Sanguine et de Biogénétique Gaetan Saleun; the Institut National de la Santé et de la Recherche Médicale, France; and the Else Kröner-Fresenius-Stiftung (2017_A108-EKFZ).
Funding Information:
Funding This work was supported in part by Grant-in-Aid from the Japan Society for the Promotion of Science (16K15421, 17K15916, 19K17450); Pancreas Research Foundation of Japan; the HIROMI Medical Research Foundation; the Mother and Child Health Foundation; the Smoking Research Foundation, the Ministry of Health, Labour, and Welfare of Japan; Conseil Régional de Bretagne; the Association des Pancréatites Chroniques Héréditaires; the Association de Transfusion Sanguine et de Biogénétique Gaetan Saleun; the Institut National de la Santé et de la Recherche Médicale, France; and the Else Kröner-Fresenius-Stiftung (2017_A108-EKFZ).The authors are grateful to Makiko Sumii, Yoko Tateda, Miyuki Tsuda, Mami Kikuchi, Makiko Nakagawa, and Kiyotaka Kuroda for the excellent technical assistance. The authors also acknowledge the technical support of the Biomedical Research Core of the Tohoku University Graduate School of Medicine. Atsushi Masamune, MD, PhD (Conceptualization: Lead; Data curation: Lead; Investigation: Lead; Methodology: Lead; Project administration: Lead; Resources: Lead; Writing – original draft: Lead; Writing – review & editing: Lead). Hiroshi Kotani, BS (Bachelor of Engineering) (Investigation: Equal; Resources: Equal). Franziska L. Sörgel, BSci (Investigation: Equal; Resources: Equal). Jian-Min Chen, MD, PhD (Investigation: Equal; Writing – review & editing: Equal). Shin Hamada, MD, PhD (Investigation: Equal; Resources: Equal). Reiko Sakaguchi, PhD (Investigation: Equal; Writing – review & editing: Equal). Emmanuelle Masson, PhD (Investigation: Equal). Eriko Nakano, MD, PhD (Funding acquisition: Supporting; Investigation: Equal). Yoichi Kakuta, MD, PhD (Data curation: Supporting; Investigation: Equal). Tetsuya Niihori, MD, PhD (Investigation: Equal; Resources: Equal). Ryo Funayama, PhD (Investigation: Equal). Matsuyuki Shirota, PhD (Investigation: Equal). Tatsuya Hirano, MS (Master of Engineering) (Investigation: Equal). Tetsuya Kawamoto, MS (Master of Engineering) (Investigation: Equal). Atsuki Hosokoshi, BS (Bachelor of Engineering) (Investigation: Equal). Kiyoshi Kume, MD, PhD (Investigation: Equal; Resources: Equal). Lara Unger, MSc (Investigation: Equal). Maren Ewers, MSci (Investigation: Equal). Helmut Laumen, PhD (Investigation: Equal). Peter Bugert, MD (Investigation: Equal). Masayuki X. Mori, PhD (Investigation: Equal). Volodymyr Tsvilovskyy, PhD (Investigation: Supporting; Methodology: Supporting). Petra Weißgerber, PhD (Investigation: Supporting; Methodology: Equal). Ulrich Kriebs, PhD (Investigation: Supporting; Methodology: Supporting). Claudia Fecher-Trost, PhD (Investigation: Supporting; Methodology: Equal). Marc Freichel, MD (Investigation: Equal). Kalliope N. Diakopoulos, PhD (Investigation: Equal; Methodology: Equal). Alexandra Berninger, MSc (Investigation: Equal). Marina Lesina, PhD (Investigation: Equal; Writing – review & editing: Supporting). Kentaro Ishii, MD (Resources: Equal). Takao Itoi, MD, PhD (Resources: Equal). Tsukasa Ikeura, MD, PhD (Resources: Equal). Kazuichi Okazaki, MD, PhD (Resources: Equal). Tom Kaune, MD (Investigation: Equal; Resources: Supporting). Jonas Rosendahl, MD (Investigation: Equal; Resources: Equal). Masao Nagasaki, PhD (Resources: Equal). Yasuhito Uezono, MD, PhD (Resources: Equal). Hana Algül, PhD (Investigation: Equal; Writing – review & editing: Equal). Keiko Nakayama, PhD (Conceptualization: Lead; Investigation: Equal; Writing – review & editing: Equal). Yoichi Matsubara, MD, PhD (Funding acquisition: Supporting; Supervision: Equal). Yoko Aoki, MD, PhD (Conceptualization: Lead; Investigation: Equal; Resources: Equal; Writing – review & editing: Supporting). Claude Férec, MD, PhD (Investigation: Equal; Project administration: Equal; Supervision: Lead). Yasuo Mori, PhD (Investigation: Equal; Supervision: Lead; Writing – review & editing: Equal). Heiko Witt, MD (Conceptualization: Lead; Funding acquisition: Supporting; Investigation: Equal; Supervision: Equal; Writing – original draft: Equal; Writing – review & editing: Equal). Tooru Shimosegawa, MD, PhD (Conceptualization: Lead; Project administration: Lead; Supervision: Equal; Writing – review & editing: Equal).
Publisher Copyright:
© 2020 AGA Institute
PY - 2020/5
Y1 - 2020/5
N2 - Background & Aims: Changes in pancreatic calcium levels affect secretion and might be involved in development of chronic pancreatitis (CP). We investigated the association of CP with the transient receptor potential cation channel subfamily V member 6 gene (TRPV6), which encodes a Ca2+-selective ion channel, in an international cohort of patients and in mice. Methods: We performed whole-exome DNA sequencing from a patient with idiopathic CP and from his parents, who did not have CP. We validated our findings by sequencing DNA from 300 patients with CP (not associated with alcohol consumption) and 1070 persons from the general population in Japan (control individuals). In replication studies, we sequenced DNA from patients with early-onset CP (20 years or younger) not associated with alcohol consumption from France (n = 470) and Germany (n = 410). We expressed TRPV6 variants in HEK293 cells and measured their activity using Ca2+ imaging assays. CP was induced by repeated injections of cerulein in TRPV6mut/mut mice. Results: We identified the variants c.629C>T (p.A210V) and c.970G>A (p.D324N) in TRPV6 in the index patient. Variants that affected function of the TRPV6 product were found in 13 of 300 patients (4.3%) and 1 of 1070 control individuals (0.1%) from Japan (odds ratio [OR], 48.4; 95% confidence interval [CI], 6.3–371.7; P = 2.4 × 10–8). Twelve of 124 patients (9.7%) with early-onset CP had such variants. In the replication set from Europe, 18 patients with CP (2.0%) carried variants that affected the function of the TRPV6 product compared with 0 control individuals (P = 6.2 × 10–8). Variants that did not affect the function of the TRPV6 product (p.I223T and p.D324N) were overrepresented in Japanese patients vs control individuals (OR, 10.9; 95% CI, 4.5–25.9; P = 7.4 × 10–9 for p.I223T and P = .01 for p.D324N), whereas the p.L299Q was overrepresented in European patients vs control individuals (OR, 3.0; 95% CI, 1.9–4.8; P = 1.2 × 10–5). TRPV6mut/mut mice given cerulein developed more severe pancreatitis than control mice, as shown by increased levels of pancreatic enzymes, histologic alterations, and pancreatic fibrosis. Conclusions: We found that patients with early-onset CP not associated with alcohol consumption carry variants in TRPV6 that affect the function of its product, perhaps by altering Ca2+ balance in pancreatic cells. TRPV6 regulates Ca2+ homeostasis and pancreatic inflammation.
AB - Background & Aims: Changes in pancreatic calcium levels affect secretion and might be involved in development of chronic pancreatitis (CP). We investigated the association of CP with the transient receptor potential cation channel subfamily V member 6 gene (TRPV6), which encodes a Ca2+-selective ion channel, in an international cohort of patients and in mice. Methods: We performed whole-exome DNA sequencing from a patient with idiopathic CP and from his parents, who did not have CP. We validated our findings by sequencing DNA from 300 patients with CP (not associated with alcohol consumption) and 1070 persons from the general population in Japan (control individuals). In replication studies, we sequenced DNA from patients with early-onset CP (20 years or younger) not associated with alcohol consumption from France (n = 470) and Germany (n = 410). We expressed TRPV6 variants in HEK293 cells and measured their activity using Ca2+ imaging assays. CP was induced by repeated injections of cerulein in TRPV6mut/mut mice. Results: We identified the variants c.629C>T (p.A210V) and c.970G>A (p.D324N) in TRPV6 in the index patient. Variants that affected function of the TRPV6 product were found in 13 of 300 patients (4.3%) and 1 of 1070 control individuals (0.1%) from Japan (odds ratio [OR], 48.4; 95% confidence interval [CI], 6.3–371.7; P = 2.4 × 10–8). Twelve of 124 patients (9.7%) with early-onset CP had such variants. In the replication set from Europe, 18 patients with CP (2.0%) carried variants that affected the function of the TRPV6 product compared with 0 control individuals (P = 6.2 × 10–8). Variants that did not affect the function of the TRPV6 product (p.I223T and p.D324N) were overrepresented in Japanese patients vs control individuals (OR, 10.9; 95% CI, 4.5–25.9; P = 7.4 × 10–9 for p.I223T and P = .01 for p.D324N), whereas the p.L299Q was overrepresented in European patients vs control individuals (OR, 3.0; 95% CI, 1.9–4.8; P = 1.2 × 10–5). TRPV6mut/mut mice given cerulein developed more severe pancreatitis than control mice, as shown by increased levels of pancreatic enzymes, histologic alterations, and pancreatic fibrosis. Conclusions: We found that patients with early-onset CP not associated with alcohol consumption carry variants in TRPV6 that affect the function of its product, perhaps by altering Ca2+ balance in pancreatic cells. TRPV6 regulates Ca2+ homeostasis and pancreatic inflammation.
KW - Genetics
KW - Next-generation Sequencing
KW - Transient Receptor Potential
KW - Whole Exome Sequencing
UR - http://www.scopus.com/inward/record.url?scp=85083549554&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85083549554&partnerID=8YFLogxK
U2 - 10.1053/j.gastro.2020.01.005
DO - 10.1053/j.gastro.2020.01.005
M3 - Article
C2 - 31930989
AN - SCOPUS:85083549554
SN - 0016-5085
VL - 158
SP - 1626-1641.e8
JO - Gastroenterology
JF - Gastroenterology
IS - 6
ER -